Similar articles

• Oral fluoropyrimidines in colorectal cancer.

  Van Cutsem E, Peeters M. Van Cutsem E, et al. Semin Oncol. 2000 Oct;27(5 Suppl 10):91-5. Semin Oncol. 2000. PMID: 11049039 Review. No abstract available.
• 5-Fluorouracil in colorectal cancer, a never ending story.

  Herrmann R. Herrmann R. Ann Oncol. 1996 Aug;7(6):551-2. doi: 10.1093/oxfordjournals.annonc.a010668. Ann Oncol. 1996. PMID: 8879365 No abstract available.
• Thymidylate synthase expression and prognosis of patients with gastrointestinal cancers receiving adjuvant chemotherapy: a review.

  Formentini A, Henne-Bruns D, Kornmann M. Formentini A, et al. Langenbecks Arch Surg. 2004 Oct;389(5):405-13. doi: 10.1007/s00423-004-0510-y. Epub 2004 Aug 12. Langenbecks Arch Surg. 2004. PMID: 15309542 Review.
• [Oral fluoropyrimidines in the treatment of colorectal carcinoma].

  Porschen R. Porschen R. Dtsch Med Wochenschr. 2003 Jun 13;128 Suppl 2:S121-3. doi: 10.1055/s-2003-40145. Dtsch Med Wochenschr. 2003. PMID: 12817344 Review. German. No abstract available.
• Novel oral fluoropyrimidines in the treatment of metastatic colorectal cancer.

  Ignoffo RJ. Ignoffo RJ. Am J Health Syst Pharm. 1999 Dec 1;56(23):2417-28; quiz 2428-9. doi: 10.1093/ajhp/56.23.2417. Am J Health Syst Pharm. 1999. PMID: 10595802 Review.